What is the long-term trend for MoonLake Immunotherapeutics's compensation and benefits?

Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's compensation and benefits has grown at a 13.1% compound annual growth rate (CAGR), from $1.42M to $2.32M.

MoonLake Immunotherapeutics MLTX Compensation and benefits

Compensation and benefits at other companies

Eli LillyLLY

——

Nektar TherapeuticsNKTR

——

Aurinia PharmaceuticalsAUPH

——

Arcutis Biotherapeutics, Inc.ARQT

——

Johnson & JohnsonJNJ

——

IncyteINCY

——

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

CapEx--100%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.49B-45.9%

Enterprise value$1.29B-50.0%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's compensation and benefits?: MoonLake Immunotherapeutics (MLTX) reported compensation and benefits of $2.2M in Q1 2026.
How has MoonLake Immunotherapeutics's compensation and benefits changed year-over-year?: MoonLake Immunotherapeutics's compensation and benefits decreased by 13.5% year-over-year, from $2.54M to $2.2M.
What is the long-term trend for MoonLake Immunotherapeutics's compensation and benefits?: Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's compensation and benefits has grown at a 13.1% compound annual growth rate (CAGR), from $1.42M to $2.32M.